NITROUS OXIDE STIMULATION OF LOCOMOTOR ACTIVITY. EVIDENCE FOR AN OPIATE-BEHAVIORAL EFFECTHYNES MD; BERKOWITZ BA.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 209; NO 2; PP. 304-308; BIBL. 18 REF.Article

EVIDENCE THAT ETHANOL-INDUCED IMPAIRMENT OF ROTO-ROD PERFORMANCE IS NOT MEDIATED BY OPIOID MECHANISMSHYMSON DL; HYNES MD.1982; PROG. NEURO-PSYCHOPHARMACOL. BIOL. PSYCHIATRY; ISSN 0278-5846; GBR; DA. 1982; VOL. 6; NO 2; PP. 159-165; BIBL. 13 REF.Article

ANTAGONISM BY (-)-METHADONE OF THE DEPLETION OF 5-HYDROXYTRYPTAMINE IN RAT BRAIN BY P-CHLOROAMPHETAMINEFULLER RW; PERRY KW; HYNES MD et al.1981; J. PHARM. PHARMACOL.; ISSN 0022-3573; GBR; DA. 1981; VOL. 33; NO 1; PP. 48-49; BIBL. 11 REF.Article

APOMORPHINE-INDUCED AGGRESSION IN RATS CHRONICALLY TREATED WITH ORAL CLONIDINE: MODULATION BY CENTRAL SEROTONERGIC MECHANISMSHAHN RA; HYNES MD; FULLER RW et al.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 2; PP. 389-393; BIBL. 2 P.Article

DIFFERENTIAL REDUCTION OF MORPHINE-WITHDRAWAL BODY SHAKES BY BUTACLAMOL ENANTIOMERS.HYNES MD; MCCARTEN MD; SHEARMAN G et al.1978; LIFE SCI.; G.B.; DA. 1978; VOL. 22; NO 1; PP. 133-136; BIBL. 18 REF.Article

SIMILARITIES AND CONTRASTS BETWEEN THE EFFECTS OF AMPHETAMINE AND APOMORPHINE INE IN RATS CHRONICALLY TREATED WITH HALOPERIDOLGIANUTSOV G; HYNES MD; DRAWBAUCH R et al.1978; PROGR. IN NEURO-PSYCHOPHARMACOL.; GBR; DA. 1978; VOL. 2; NO 2; PP. 161-167; BIBL. 2 P.Article

PARADOXICAL ABSENCE OF AGGRESSION DURING NALOXONE-PRECIPITATED MORPHINE WITHDRAWAL. = L'ABSENCE PARADOXALE D'AGRESSIVITE AU COURS DU SYNDROME DU SEVRAGE DE LA MORPHINE PRECIPITE PAR LA NALOXONEGIANUTSOS G; HYNES MD; DRAWBAUGH RB et al.1975; PSYCHOPHARMACOLOGIA; ALLEM.; DA. 1975; VOL. 43; NO 1; PP. 43-46; BIBL. 17 REF.Article

EFFECTS OF HALOPERIDOL, METHYLTHYROSINE AND MORPHINE ON RECOVERY FROM LESIONS OF LATERAL HYPOTHALAMUS.HYNES MD; ANDERSON CD; GIANUTSOS G et al.1975; PHARMACOL. BIOCHEM. BEHAV.; U.S.A.; DA. 1975; VOL. 3; NO 5; PP. 755-759; BIBL. 40 REF.Article

RESOLUTION AND ABSOLUTE CONFIGURATION OF AN ERGOLINE-RELATED DOPAMINE AGONIST, TRANS-4,4A,5,6,7,8,8A,9-OCTAHYDRO-5-PROPYL-1H (OR 2H)-PYRAZOLO (3,4-G) QUINOLINETITUS RD; KORNFELD EC; JONES ND et al.1983; JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0022-2623; USA; DA. 1983; VOL. 26; NO 8; PP. 1112-1116; BIBL. 19 REF.Article